Novartis Ag (NVS) Other Working Capital Changes (2009 - 2026)

Novartis Ag (NVS) has 16 years of Other Working Capital Changes data on file, last reported at $70.0 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 61.54% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$197.0 million (up 68.73% YoY) and the FY2017 annual result came in at $160.0 million, down 83.26% from the prior year.
• Other Working Capital Changes eased to $70.0 million in Q1 2026 per NVS's latest filing, from $182.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $182.0 million in Q1 2025, with the low at -$363.0 million in Q1 2022.
• Average Other Working Capital Changes over 5 years is -$112.0 million, with a median of -$177.0 million recorded in 2023.
• Year-over-year, Other Working Capital Changes plunged 231.05% in 2022 and jumped 166.91% in 2025.
• Novartis Ag's Other Working Capital Changes stood at -$363.0 million in 2022, then surged by 51.24% to -$177.0 million in 2023, then tumbled by 53.67% to -$272.0 million in 2024, then jumped by 166.91% to $182.0 million in 2025, then tumbled by 61.54% to $70.0 million in 2026.
• Business Quant data shows NVS's Other Working Capital Changes at $70.0 million in Q1 2026, $182.0 million in Q1 2025, and -$272.0 million in Q1 2024.